Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21 R-mediated JAK2/STAT3 pathway

被引:30
|
作者
Huang, Yanxia [1 ,2 ]
Zhang, Jing [2 ]
Wang, Ge [2 ]
Chen, Xiaoyu [2 ]
Zhang, Rui [2 ]
Liu, Hui [2 ]
Zhu, Jinshui [2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China
关键词
gastric cancer; growth; IL-21R; JAK2; oxymatrine; STAT3; INTERLEUKIN-21; RECEPTOR; IN-VITRO; GROWTH; CELLS; LYMPHOMA; PROLIFERATION;
D O I
10.1177/2058738418781634
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oxymatrine (OMT) as a type of alkaloids collected from Sophora flavescens Ait exerts some biological functions including anticancer properties. Here, we investigated the therapeutic effects of OMT in gastric cancer cells (HGC 27 and AGS). As a result, the exposure of gastric cancer (GC) cells to OMT contributed to the suppression of cell proliferation and invasion. Interleukin 21 receptor (IL-21R) was identified to be differentially expressed between OMT treatment group (4mg/mL) and control group (0 mg/mL), and knockdown of IL-21 R repressed cell proliferation and invasion via inactivation of the JAK2/STAT3 pathway. The rescue experiment showed that IL-21R overexpression attenuated the anti-tumor effects of OMT through activation of the JAK2/STAT3 pathway. Moreover, the expression of IL-21R was significantly upregulated in GC samples compared with the adjacent normal tissues and associated with overall survival (OS) and tumor recurrence of GC patients. Taken together, in this study, we evaluated the anti-tumor effects of OMT on GC by investigating proliferation and invasion ability changes, and our findings show that OMT exhibits effects via regulation of JAK/STAT signaling pathway. Through the mechanism study, we may enlighten the potential therapeutic target for treatment of GC.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway
    Sun, Qian
    Lu, Na-Na
    Feng, Lei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 498 (01) : 164 - 170
  • [42] Anti-IL-23 exerted protective effects on cerebral ischemia–reperfusion injury through JAK2/STAT3 signaling pathway
    Lichao Fan
    Lichun Zhou
    Molecular Biology Reports, 2021, 48 : 3475 - 3484
  • [43] CAFs enhance paclitaxel resistance by inducing EMT through the IL-6/JAK2/STAT3 pathway
    Wang, Linlin
    Zhang, Fang
    Cui, Jian-Ying
    Chen, Liang
    Chen, Yue-Ting
    Liu, Bo-Wen
    ONCOLOGY REPORTS, 2018, 39 (05) : 2081 - 2090
  • [44] IL-6 upregulates the expression of IL-6R through the JAK2/STAT3 signalling pathway to promote progression of hepatocellular carcinoma
    Song, Li
    Xu, Ruyue
    Cai, Wenpeng
    Liang, Jiaojiao
    Cao, Niandie
    Gao, Jiafeng
    Tang, Xiaolong
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 98 (01)
  • [45] Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the JAK2/STAT3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment
    Ren, Pengfei
    Tang, Qingjuan
    He, Xinjia
    Xu, Jie
    Wang, Yuming
    Xue, Changhu
    MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (02)
  • [46] Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
    Zhang, Wentao
    Yang, Fuhan
    Zheng, Zongtai
    Li, Cheng
    Mao, Shiyu
    Wu, Yuan
    Wang, Ruiliang
    Zhang, Junfeng
    Zhang, Yue
    Wang, Hong
    Li, Wei
    Huang, Jianhua
    Yao, Xudong
    CANCERS, 2023, 15 (01)
  • [47] Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways
    Wu, Liangrong
    Qian, Chenchen
    Zhang, Weiqi
    Shi, Mengyun
    Chen, Xiuxiu
    Wang, Yi
    Lin, Feng
    PHYTOMEDICINE, 2023, 116
  • [48] IL-9 promotes proliferation and metastasis of hepatocellular cancer cells by activating JAK2/STAT3 pathway
    Lei, Rong-E
    Shi, Cheng
    Zhang, Pei-Ling
    Hu, Bang-Li
    Jiang, Hai-Xing
    Qin, Shang-Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (07): : 7940 - 7946
  • [49] Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
    Abubaker, Khalid
    Luwor, Rodney B.
    Zhu, Hongjian
    McNally, Orla
    Quinn, Michael A.
    Burns, Christopher J.
    Thompson, Erik W.
    Findlay, Jock K.
    Ahmed, Nuzhat
    BMC CANCER, 2014, 14
  • [50] Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells
    Han, Songhee
    Jeong, Ae Jin
    Yang, Heejung
    Bin Kang, Kyo
    Lee, Haeri
    Yi, Eun Hee
    Kim, Byung-Hak
    Cho, Chung-Hyun
    Chung, Jin Woong
    Sung, Sang Hyun
    Ye, Sang-Kyu
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 194 : 83 - 90